Case Study | May 05, 2011

RFID Aids Radiation Therapy Patient Identification

May 5, 2011 – At the 2011 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition at the ExCel Centre in London, Elekta will demonstrate advanced solutions that provide clinicians with the tools to save and improve lives of cancer patients worldwide. This includes Elekta's new RFID system, Identify, which is designed to increase staff confidence in the integrity of patient identification and set up.

Identify harnesses precision radiofrequency identification technology and will ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify will feature complete integration with Elekta's Mosaiq Oncology Information System, enabling patient queuing, selection of patient details in monitoring of set-up position, optimizing workflow and enhancing safety. Identify will be a scalable solution – from the treatment room to the entire department – allowing centers to grow as needs change.

Throughout the five major solution areas at the Elekta booth, the company will demonstrate how its digital platforms offer robust upgrade paths to accommodate a wide range of clinical requirements. The solution areas are:
Secure Workflow – personalized efficiency
Stereotaxy – premium solutions for the most challenging cases
Delivery – clinically focused, digitally controlled
Imaging – inspiring clinical confidence
Quality Assurance – completing the picture

In addition, Elekta will host a lunch symposium titled Throughput with Confidence on Monday, May 9 at the Capital Suites. The symposium will feature presentations by notable experts in the field of radiation oncology:
Professor Frank Lohr, University Hospital, Mannheim, Germany: Efficient VMAT Planning and Delivery
Ben J. Mijnheer, Ph.D., NKI/AvL, Amsterdam, Netherlands: Experiences from AvL with EPID-based In-Vivo Dosimetry
PD Reinhart A. Sweeney, University Hospital, Wurzburg, Germany; Christian Hieronimi, Elekta: Identify - who, what, where and how. Now!

For more information: www.elekta.com

Related Content

Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...